Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the Brain

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Alternate Title

Phase II Study of Hypofractionated Highly Conformal Radiotherapy With Helical Tomotherapy in Patients With Extracranial Oligometastases

Basic Trial Information

PhaseTypeStatusAgeSponsorProtocol IDs
Phase IITreatmentCompletedOver 18NCINCI-07-C-0230
07-C-0230, NCT00550654

Special Category: NIH Clinical Center trial, NCI Web site featured trial

Trial Description


Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue.

This phase II trial is studying how well conformal radiation therapy works in treating patients with metastatic cancer outside the brain.


Eligibility criteria include the following:

Final eligibility for a clinical trial is determined by the health professionals conducting the trial.


Patients will undergo conformal radiation therapy every other day for 5 days (three treatments). They will also undergo an imaging procedure before and after each treatment.

Patients will fill out a pain questionnaire at the beginning of the study and at 1 and 3 months after finishing treatment.

After finishing treatment, patients will be evaluated at 1 and 3 months and every 3 months for up to 1 year.


For more details about this trial, refer to the Health Professional version of the trial summary.

If you are interested in participating in a clinical trial, contact your doctor for a referral or call a trial contact person listed below. You may see the same contact person listed at more than one site, however, if you call the number listed you can ask to speak to the study coordinator or person involved with the specific trial you are interested in. If you have questions about cancer or clinical trials, call the Cancer Information Service at 1-800-4-CANCER (1-800-422-6237). General information about clinical trials, including risks, benefits, and costs, can be found on NCI's Web site.

Trial Contact Information

Trial Lead Organizations

NCI - Center for Cancer Research

Deborah Citrin, MD, Principal investigator
Ph: 301-496-5457

Related Information

Featured trial article

Registry Information

Official TitleA Phase II Study of Hypofractionated Highly Conformal Radiation with Helical Tomotherapy for Extra-Cranial Oligo
Trial Start Date2007-10-02
Trial Completion Date2010-05-06
Registered in ClinicalTrials.govNCT00550654
Date Submitted to PDQ2007-10-02
Information Last Verified2009-06-07